Drug Management of Prostate Cancer

Nonfiction, Health & Well Being, Medical, Specialties, Urology, Oncology
Cover of the book Drug Management of Prostate Cancer by , Springer New York
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781603278294
Publisher: Springer New York Publication: September 14, 2010
Imprint: Springer Language: English
Author:
ISBN: 9781603278294
Publisher: Springer New York
Publication: September 14, 2010
Imprint: Springer
Language: English

Prostate cancer is the most common noncutaneous prostate cancer. Research has revealed several distinct malignancy and the second leading cause of cancer mechanisms of castration-resistant disease that may deaths among men in the United States. It is a critical converge in patients with disease progression on public health problem and remains incurable in the ADT. Many approaches are currently being evaluated metastatic setting with mortality that usually occurs as to improve the treatment of this condition and these a result of castration-resistant disease. fndings have identifed several potential targets for Since Huggins and Hodges’ report of the dra- therapeutic intervention. These include drugs that are matic clinical effects of suppressing serum testos- more active or less toxic chemotherapy agents; drugs terone levels in men with advanced prostate cancer that induce androgen deprivation; drugs that target in 1941, hormone therapy (also called androgen the androgen receptor and/or androgen synthesis; deprivation therapy [ADT]) has become widely drugs that target specifc pathways, including ang- accepted as the mainstay of therapy for the treat- genesis and tyrosine kinase inhibitors, endothelin ment of advanced prostate cancer. ADT combined antagonists and matrix metalloproteinase inhibitors; with radiation therapy is a standard of care in the and immunologic approaches. Many of these agents treatment of men with locally advanced prostate seem promising and the rationale and effcacy of cancer on the basis of evidence that shows improved these emerging therapies remain to be validated in survival. The role of ADT in the management of future clinical trials.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Prostate cancer is the most common noncutaneous prostate cancer. Research has revealed several distinct malignancy and the second leading cause of cancer mechanisms of castration-resistant disease that may deaths among men in the United States. It is a critical converge in patients with disease progression on public health problem and remains incurable in the ADT. Many approaches are currently being evaluated metastatic setting with mortality that usually occurs as to improve the treatment of this condition and these a result of castration-resistant disease. fndings have identifed several potential targets for Since Huggins and Hodges’ report of the dra- therapeutic intervention. These include drugs that are matic clinical effects of suppressing serum testos- more active or less toxic chemotherapy agents; drugs terone levels in men with advanced prostate cancer that induce androgen deprivation; drugs that target in 1941, hormone therapy (also called androgen the androgen receptor and/or androgen synthesis; deprivation therapy [ADT]) has become widely drugs that target specifc pathways, including ang- accepted as the mainstay of therapy for the treat- genesis and tyrosine kinase inhibitors, endothelin ment of advanced prostate cancer. ADT combined antagonists and matrix metalloproteinase inhibitors; with radiation therapy is a standard of care in the and immunologic approaches. Many of these agents treatment of men with locally advanced prostate seem promising and the rationale and effcacy of cancer on the basis of evidence that shows improved these emerging therapies remain to be validated in survival. The role of ADT in the management of future clinical trials.

More books from Springer New York

Cover of the book Male Sterility and Motility Disorders by
Cover of the book Quantum-Limit Spectroscopy by
Cover of the book Episodes in the Mathematics of Medieval Islam by
Cover of the book Reviews of Environmental Contamination and Toxicology by
Cover of the book Space Manifold Dynamics by
Cover of the book Essentials of Percutaneous Dialysis Interventions by
Cover of the book Immunologic Signatures of Rejection by
Cover of the book Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease by
Cover of the book Transition to Parenthood by
Cover of the book Recovery of Gray Wolves in the Great Lakes Region of the United States by
Cover of the book Seeds by
Cover of the book Lecture Notes on the General Theory of Relativity by
Cover of the book Regression Modeling Strategies by
Cover of the book Medical Imaging Technology by
Cover of the book Duplex Sonography by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy